急性細菌性皮膚・皮膚構造感染症の世界市場レポート 2025年

急性細菌性皮膚・皮膚構造感染症市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.9%で189億9,000万米ドルに成長します。予測期間の成長は、世界の疫学的要因、新しい治療法の市場参入、迅速な診断ツール、患者中心のアプローチ、治療ガイドラインの変化などに起因すると考えられます。予測期間の主な動向には、患者人口統計、抗生物質耐性懸念、治療戦略の進歩、メチシリン耐性黄色ブドウ球菌（mrsa）の流行、外来治療の重視などがあります。

皮膚感染症の急増が市場成長の原動力に皮膚感染症の増加が、今後の急性細菌性皮膚・皮膚構造感染症市場の成長を牽引すると予測されています。皮膚感染症は、細菌、真菌、ウイルスなどの微生物が皮膚内に侵入して増殖することで発生し、さまざまな症状や不快感をもたらします。皮膚感染症の増加は、急性細菌感染症や皮膚構造感染症を管理するための治療ソリューション、抗生物質、革新的な治療法に対する需要の高まりを生み出し、患者が最適な治療と転帰を得られるようにします。例えば、2023年3月、スイスに本部を置く国連の専門機関である世界保健機関（WHO）は、世界中で常時約18億人が皮膚疾患に苦しんでいると報告しました。顧みられない熱帯病（Neglected Tropical Diseases：NTDs）はその約10％を占め、真菌感染症が34％、細菌感染症が23％を占め、しばしば大きな死亡率につながります。そのため、皮膚感染症の有病率の増加は、急性細菌性皮膚・皮膚構造感染症市場の成長を促進すると予想されます。

慢性疾患の増加も、今後数年間の急性細菌性皮膚・皮膚構造感染症市場の成長を後押しすると予測されています。慢性疾患は、ゆっくりと進行し、長期間にわたって持続する長期的な病状を特徴とし、多くの場合、数年または生涯にわたって持続します。慢性疾患の増加は、細菌性皮膚感染症のリスクを高め、治療、入院、専門的ケア、調査、社会的認識、ヘルスケア支出、罹患者への個別介入を増加させることにより、急性細菌性皮膚・皮膚構造感染症市場に貢献しています。一例として、世界保健機関（WHO）は2022年9月、非感染性疾患（NCDs）または慢性疾患による世界の死亡者数4,100万人のうち74％が毎年死亡していると報告しました。その内訳は、心血管疾患が1790万人、がんが930万人、慢性呼吸器疾患が410万人、糖尿病が200万人です。したがって、慢性疾患の有病率の増加が急性細菌性皮膚・皮膚構造感染症市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界急性細菌性皮膚・皮膚構造感染症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の急性細菌性皮膚・皮膚構造感染症市場：成長率分析
• 世界の急性細菌性皮膚・皮膚構造感染症市場の実績：規模と成長, 2019-2024
• 世界の急性細菌性皮膚・皮膚構造感染症市場の予測：規模と成長, 2024-2029, 2034F
• 世界急性細菌性皮膚・皮膚構造感染症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の急性細菌性皮膚・皮膚構造感染症市場感染の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 院内感染急性細菌性皮膚・皮膚構造感染症
• コミュニティが獲得した急性細菌性皮膚・皮膚構造感染症
• 世界の急性細菌性皮膚・皮膚構造感染症市場有効成分別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デラフロキサシン
• バンコマイシン
• セフタロリンフォサミル
• オリタヴァンシン
• テジゾリド
• ダプトマイシン
• チゲサイクリン
• リネゾリド
• その他の有効成分
• 世界の急性細菌性皮膚・皮膚構造感染症市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 話題
• 世界の急性細菌性皮膚・皮膚構造感染症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の急性細菌性皮膚・皮膚構造感染症市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蜂窩織炎
• 膿瘍
• 手術創
• 外傷
• 世界の急性細菌性皮膚・皮膚構造感染症市場、院内感染急性細菌性皮膚・皮膚構造感染症（HABSSSI）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術部位感染
• カテーテル関連感染症
• 褥瘡
• 医療機器に関連する感染症
• 世界の急性細菌性皮膚・皮膚構造感染症市場、コミュニティ獲得急性細菌性皮膚・皮膚構造感染症（CABSSSI）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蜂窩織炎
• 膿瘍
• 伝染性膿痂疹
• 毛包炎
• 創傷感染

第7章 地域別・国別分析

• 世界の急性細菌性皮膚・皮膚構造感染症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の急性細菌性皮膚・皮膚構造感染症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性細菌性皮膚・皮膚構造感染症市場：競合情勢
• 急性細菌性皮膚・皮膚構造感染症市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GSK PLC
• Takeda Pharmaceutical Company Limited
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Aspen Pharmacare Holdings Limited
• Lupin Limited
• Zydus Lifesciences Limited
• Eurofarma Laboratorios S.A.
• Glenmark Pharmaceuticals Ltd.
• Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
• Alkem Laboratories Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 急性細菌性皮膚・皮膚構造感染症市場2029：新たな機会を提供する国
• 急性細菌性皮膚・皮膚構造感染症市場2029：新たな機会を提供するセグメント
• 急性細菌性皮膚・皮膚構造感染症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acute bacterial skin and skin structure infections (ABSSSIs) represent a category of skin infections caused by bacteria impacting both the skin and underlying tissues, resulting in symptoms such as redness, swelling, pain, and increased warmth in the affected region. Medical interventions, including antibiotic treatments, are employed to prevent complications and facilitate recovery in cases ranging from mild to severe infections.

The primary classifications of acute bacterial skin and skin structure infections encompass hospital-acquired ABSSSIs and community-acquired ABSSSIs. Hospital-acquired ABSSSIs manifest as infections of the skin and underlying tissues that develop due to medical care or hospital stays. Active ingredients in treatments include delafloxacin, vancomycin, ceftaroline fosamil, oritavancin, tedizolid, daptomycin, tigecycline, linezolid, and others, with administration options including oral, parenteral, and topical routes. These treatments are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, addressing various applications such as cellulitis, abscesses, surgical wounds, and traumatic wounds.

The acute bacterial skin and skin structure infections market research report is one of a series of new reports from The Business Research Company that provides acute bacterial skin and skin structure infections market statistics, including acute bacterial skin and skin structure infections industry global market size, regional shares, competitors with a acute bacterial skin and skin structure infections market share, detailed acute bacterial skin and skin structure infections market segments, market trends and opportunities, and any further data you may need to thrive in the acute bacterial skin and skin structure infections industry. This acute bacterial skin and skin structure infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute bacterial skin and skin structure infections market size has grown rapidly in recent years. It will grow from $11.75 billion in 2024 to $13.03 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to healthcare industry innovation, economic factors, patient population trends, evolving diagnostic methods, clinical trial innovation.

The acute bacterial skin and skin structure infections market size is expected to see strong growth in the next few years. It will grow to $18.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to global epidemiological factors, market entry of new therapies, rapid diagnostic tools, patient-centric approach, shifting treatment guidelines. Major trends in the forecast period include patient population demographics, antibiotic resistance concerns, advancements in treatment strategies, prevalence of methicillin-resistant staphylococcus aureus (mrsa), focus on outpatient treatment.

The anticipated surge in the prevalence of skin infections is poised to drive the growth of the market The increasing prevalence of skin infections is anticipated to drive the growth of the acute bacterial skin and skin structure infections market in the future. Skin infections occur when microorganisms, such as bacteria, fungi, or viruses, invade and multiply within the skin, resulting in various symptoms and discomfort. The rise in skin infections generates a heightened demand for therapeutic solutions, antibiotics, and innovative treatments to manage acute bacterial and skin structure infections, ensuring that patients have access to optimal care and outcomes. For example, in March 2023, the World Health Organization (WHO), a specialized agency of the United Nations based in Switzerland, reported that approximately 1.8 billion people worldwide suffer from skin conditions at any given time. Neglected tropical diseases (NTDs) account for about 10% of these cases, with fungal infections representing 34% and bacterial infections 23%, often leading to significant mortality rates. Therefore, the rising prevalence of skin infections is expected to propel the growth of the acute bacterial skin and skin structure infections market.

The increasing prevalence of chronic diseases is also anticipated to boost the growth of the acute bacterial skin and skin structure infections market in the coming years. Chronic diseases are characterized by long-term medical conditions that progress slowly and persist over an extended period, often lasting for years or a lifetime. The growth of chronic diseases contributes to the acute bacterial skin and skin structure infections market by heightening the risk of bacterial skin infections, necessitating increased treatments, hospitalizations, specialized care, research, public awareness, healthcare spending, and tailored interventions for affected individuals. As an illustration, the World Health Organization reported in September 2022 that 74% of the 41 million global deaths caused by non-communicable diseases (NCDs) or chronic diseases annually. The deaths included 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the increasing prevalence of chronic diseases is a driving force behind the growth of the acute bacterial skin and skin structure infections market.

Major companies operating in the acute bacterial skin and skin structure infections market are strategically focusing on developing innovative single-dose therapies, such as Dalbonova, to gain a competitive edge. Dalbonova is a single-dose therapy designed for convenience and effectiveness, allowing patients to achieve desired results with a potent 1500 mg dose administered once. For example, in August 2023, BDR Pharmaceuticals Internationals Pvt. Ltd., an India-based pharmaceutical company, launched Dalbonova injection, a single-dose therapy for acute bacterial skin and skin structure infections (ABSSSI). This injection reduces the risk of hospital-acquired diseases by offering a single-dose treatment and eliminating the need for hospital admissions. It is designed to treat ABSSSI caused by certain gram-positive microorganisms in patients of all ages, including newborns.

In July 2023, Melinta Therapeutics, a pharmaceutical company based in the U.S., partnered with the Biomedical Advanced Research and Development Authority (BARDA) to advance two FDA-approved antibiotics, Baxdela and Minocin, for use in pediatric patients. This collaboration aims to enhance Melinta's pipeline in hematology by leveraging Imago BioSciences' innovative therapies for myeloproliferative neoplasms and other bone marrow diseases, thereby expanding its ability to provide breakthrough treatments for patients facing these serious conditions. The Biomedical Advanced Research and Development Authority is a U.S. government agency focused on developing and acquiring medical countermeasures to safeguard the nation against public health threats.

Major companies operating in the acute bacterial skin and skin structure infections market report are Pfizer Inc., AbbVie Inc., Novartis AG, Abbott Laboratories, Fresenius SE & Co. KGaA, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Menarini Group, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Zydus Lifesciences Limited, Eurofarma Laboratorios S.A., Glenmark Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Alkem Laboratories Limited, Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd., Aurobindo Pharma Limited, Zhejiang Jingxin Pharmaceutical Co. Ltd., ACS Dobfar SpA, Melinta Therapeutics LLC, Shandong Luoxin Pharmaceutical Group Co. Ltd., Wakunaga Pharmaceutical Co. Ltd., Flynn Pharma Ltd.

Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acute bacterial skin and skin structure infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute bacterial skin and skin structure infections market consists of revenues earned by entities by providing services such as diagnostic testing, surgical procedures for abscess drainage or debridement, inpatient and outpatient healthcare services, and home healthcare and wound care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute bacterial skin and skin structure infections market also includes sales of wound dressings and bandages, medical devices for wound care, vaccines, hydrogen peroxide, and fusidic acid. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute bacterial skin and skin structure infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute bacterial skin and skin structure infections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute bacterial skin and skin structure infections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections; Community-Acquired Acute Bacterial Skin And Skin Structure Infections
• 2) By Active Ingredients: Delafloxacin; Vancomycin; Ceftaroline Fosamil; Oritavancin; Tedizolid; Daptomycin; Tigecycline; Linezolid; Other Active Ingredients
• 3) By Route Of Administration: Oral; Parenteral; Topical
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By Application: Cellulitis; Abscess; Surgical Wounds; Traumatic Wound
• Subsegments:
• 1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections; Catheter-Related Infections; Pressure Ulcers; Infections Related To Medical Devices
• 2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis; Abscesses; Impetigo; Folliculitis; Wound Infections
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Novartis AG; Abbott Laboratories; Fresenius SE & Co. KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Bacterial Skin And Skin Structure Infections Market Characteristics

3. Acute Bacterial Skin And Skin Structure Infections Market Trends And Strategies

4. Acute Bacterial Skin And Skin Structure Infections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Acute Bacterial Skin And Skin Structure Infections Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Bacterial Skin And Skin Structure Infections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Bacterial Skin And Skin Structure Infections Market Growth Rate Analysis
• 5.4. Global Acute Bacterial Skin And Skin Structure Infections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Bacterial Skin And Skin Structure Infections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Bacterial Skin And Skin Structure Infections Total Addressable Market (TAM)

6. Acute Bacterial Skin And Skin Structure Infections Market Segmentation

• 6.1. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital-acquired Acute Bacterial Skin And Skin Structure Infections
• Community-acquired Acute Bacterial Skin And Skin Structure Infections
• 6.2. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Delafloxacin
• Vancomycin
• Ceftaroline fosamil
• Oritavancin
• Tedizolid
• Daptomycin
• Tigecycline
• Linezolid
• Other Active Ingredients
• 6.3. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Topical
• 6.4. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellulitis
• Abscess
• Surgical Wounds
• Traumatic Wound
• 6.6. Global Acute Bacterial Skin And Skin Structure Infections Market, Sub-Segmentation Of Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Site Infections
• Catheter-Related Infections
• Pressure Ulcers
• Infections Related To Medical Devices
• 6.7. Global Acute Bacterial Skin And Skin Structure Infections Market, Sub-Segmentation Of Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellulitis
• Abscesses
• Impetigo
• Folliculitis
• Wound Infections

7. Acute Bacterial Skin And Skin Structure Infections Market Regional And Country Analysis

• 7.1. Global Acute Bacterial Skin And Skin Structure Infections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Bacterial Skin And Skin Structure Infections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market

• 8.1. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Bacterial Skin And Skin Structure Infections Market

• 9.1. China Acute Bacterial Skin And Skin Structure Infections Market Overview
• 9.2. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Bacterial Skin And Skin Structure Infections Market

• 10.1. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Bacterial Skin And Skin Structure Infections Market

• 11.1. Japan Acute Bacterial Skin And Skin Structure Infections Market Overview
• 11.2. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Bacterial Skin And Skin Structure Infections Market

• 12.1. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Bacterial Skin And Skin Structure Infections Market

• 13.1. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Bacterial Skin And Skin Structure Infections Market

• 14.1. South Korea Acute Bacterial Skin And Skin Structure Infections Market Overview
• 14.2. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Bacterial Skin And Skin Structure Infections Market

• 15.1. Western Europe Acute Bacterial Skin And Skin Structure Infections Market Overview
• 15.2. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Bacterial Skin And Skin Structure Infections Market

• 16.1. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Bacterial Skin And Skin Structure Infections Market

• 17.1. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Bacterial Skin And Skin Structure Infections Market

• 18.1. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Bacterial Skin And Skin Structure Infections Market

• 19.1. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Bacterial Skin And Skin Structure Infections Market

• 20.1. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market

• 21.1. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market Overview
• 21.2. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Bacterial Skin And Skin Structure Infections Market

• 22.1. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Bacterial Skin And Skin Structure Infections Market

• 23.1. North America Acute Bacterial Skin And Skin Structure Infections Market Overview
• 23.2. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Bacterial Skin And Skin Structure Infections Market

• 24.1. USA Acute Bacterial Skin And Skin Structure Infections Market Overview
• 24.2. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Bacterial Skin And Skin Structure Infections Market

• 25.1. Canada Acute Bacterial Skin And Skin Structure Infections Market Overview
• 25.2. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Bacterial Skin And Skin Structure Infections Market

• 26.1. South America Acute Bacterial Skin And Skin Structure Infections Market Overview
• 26.2. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Bacterial Skin And Skin Structure Infections Market

• 27.1. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Bacterial Skin And Skin Structure Infections Market

• 28.1. Middle East Acute Bacterial Skin And Skin Structure Infections Market Overview
• 28.2. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Bacterial Skin And Skin Structure Infections Market

• 29.1. Africa Acute Bacterial Skin And Skin Structure Infections Market Overview
• 29.2. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Bacterial Skin And Skin Structure Infections Market Competitive Landscape And Company Profiles

• 30.1. Acute Bacterial Skin And Skin Structure Infections Market Competitive Landscape
• 30.2. Acute Bacterial Skin And Skin Structure Infections Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Acute Bacterial Skin And Skin Structure Infections Market Other Major And Innovative Companies

• 31.1. GSK PLC
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Sun Pharmaceutical Industries Limited
• 31.6. Menarini Group
• 31.7. Dr. Reddy's Laboratories Ltd.
• 31.8. Cipla Limited
• 31.9. Aspen Pharmacare Holdings Limited
• 31.10. Lupin Limited
• 31.11. Zydus Lifesciences Limited
• 31.12. Eurofarma Laboratorios S.A.
• 31.13. Glenmark Pharmaceuticals Ltd.
• 31.14. Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
• 31.15. Alkem Laboratories Limited

32. Global Acute Bacterial Skin And Skin Structure Infections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Bacterial Skin And Skin Structure Infections Market

34. Recent Developments In The Acute Bacterial Skin And Skin Structure Infections Market

35. Acute Bacterial Skin And Skin Structure Infections Market High Potential Countries, Segments and Strategies

• 35.1 Acute Bacterial Skin And Skin Structure Infections Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Bacterial Skin And Skin Structure Infections Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Bacterial Skin And Skin Structure Infections Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer